Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials

Venous thromboembolism (VTE) is a common complication in cancer patients [1, 2], associated with an 8–10% annual bleeding risk during anticoagulant therapy and a 10–20% annual risk of VTE recurrence [1, 3].
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Pulmonary vascular disease Original Articles: Research letters Source Type: research